Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiaging Vaccines Targeting Senescent Cells
Andrew R. Mendelsohn, James W. Larrick
Rejuvenation Research (2022) Vol. 25, Iss. 1, pp. 39-45
Closed Access | Times Cited: 22

Showing 22 citing articles:

Cellular senescence: the good, the bad and the unknown
Weijun Huang, LaTonya J. Hickson, Alfonso Eirin, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 10, pp. 611-627
Open Access | Times Cited: 630
Inflammatory Mediators of Endothelial Dysfunction
Eirini Dri, Evangelos Lampas, George Lazaros, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 42
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
V. Lelarge, Remi Capelle, Frédérik Oger, et al.
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 30
How age affects human hematopoietic stem and progenitor cells and strategies to mitigate HSPC aging
Xueling Li, Jianwei Wang, Linping Hu, et al.
Experimental Hematology (2025), pp. 104711-104711
Closed Access | Times Cited: 2
The ageing immune system as a potential target of senolytics
Peter Yandi Du, Ankesh Gandhi, Manraj Bawa, et al.
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 12
The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities
Zehua Wang, Chen Chen, Jiaoyu Ai, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction
Kexin Zhang, Qiliang Yin, Y.F. Ma, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice
Andrea Molnár, Dorottya Pásztor, Zsófia Tarcza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17129-17129
Open Access | Times Cited: 7
Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): An Attractive Target in Atherosclerosis
Xiaochen Yu, Min Li, Chao Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 732, pp. 150386-150386
Closed Access | Times Cited: 2
Senotherapy, cancer, and aging
Lodovico Balducci, Claire Falandry, S. Monfardini
Journal of Geriatric Oncology (2023) Vol. 15, Iss. 4, pp. 101671-101671
Closed Access | Times Cited: 6
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Zoë J. Williams, Lyndah Chow, Steven P. Dow, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Seno-antigen-pulsed dendritic cell vaccine induce anti-aging immunity to improve adipose tissue senescence and metabolic abnormalities
Yin Cao, Xiaoxue Du, Jiahong Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117433-117433
Closed Access | Times Cited: 1
Pour une meilleure immunité : l’approche du parcours de vie pour une longévité en bonne santé
Organisation panaméricaine de la Santé
Pan American Health Organization eBooks (2024)
Open Access
Prevention of Chronic Kidney Disease and Its Complications in Older Adults
Somkanya Tungsanga, Aminu K. Bello
Drugs & Aging (2024) Vol. 41, Iss. 7, pp. 565-576
Closed Access
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Eloi Parladé, Annabel García‐León, Eric Voltà‐Durán, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 202, pp. 114410-114410
Open Access
Cellular senescence: A novel therapeutic target for central nervous system diseases
Shuang-Yin Lei, Yang Qu, Yu-Qian Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117311-117311
Open Access
Senolytic Vaccines from the Central and Peripheral Tolerance Perspective
Maria Vasilieva, Rimma O. Shatalova, Kseniia S. Matveeva, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1389-1389
Open Access
Can senolysis be used to overcome tumor immune evasion?
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
Para uma melhor imunidade: abordagem de curso de vida para uma longevidade saudável

(2024)
Open Access
Maintaining a ‘fit’ immune system: the role of vaccines
Béatrice Laupèze, T. Mark Doherty
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 256-266
Open Access
Building Better Immunity: A Life Course Approach to Healthy Longevity
Pan American Health Organization
(2023)
Open Access
Lograr una mejor inmunidad: el enfoque de curso de vida para una longevidad saludable
Organización Panamericana de la Salud
(2023)
Open Access
Page 1

Scroll to top